| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2023 ( Subtotal = $22,550,882 ) (Continued on the next page) |
| | 2023 | 2023 | INSTITUTE FOR CANCER RESEARCH, THE | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | UG3HL170034 | Asian American Community Cohort and Equity Study (ACCESS) | 000 | 1 | NIH | 8/4/2023 | $80,001 |
| | 2023 | 2023 | INSTITUTE FOR CANCER RESEARCH, THE | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R56AI168087 | Harnessing ZBP1-triggered cell death to enhance influenza vaccine responsiveness | 000 | 1 | NIH | 8/4/2023 | $833,534 |
| | 2023 | 2023 | INSTITUTE FOR CANCER RESEARCH, THE | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R35GM144131 | Deciphering Networks Controlling DNA Amplification | 000 | 2 | NIH | 11/8/2022 | $420,750 |
| | 2023 | 2023 | INSTITUTE FOR CANCER RESEARCH, THE | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R01CA236391 | Novel Role of ThPOK in Mammary Carcinoma | 000 | 5 | NIH | 3/28/2023 | $622,664 |
| | 2023 | 2023 | INSTITUTE FOR CANCER RESEARCH, THE | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R00CA263017 | The role of MER/PROS1 in promoting stromal induced emergence from metastatic melanoma dormancy | 000 | 2 | NIH | 5/9/2023 | $249,000 |
| | 2023 | 2023 | INSTITUTE FOR CANCER RESEARCH, THE | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R03HS029223 | Modeling Therapy Sequence for Advanced Cancer: A Microsimulation Approach Using Real-World Data | 000 | 2 | AHRQ | 8/18/2023 | $50,000 |
| | 2023 | 2023 | INSTITUTE FOR CANCER RESEARCH, THE | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R25CA259244 | Empowering the Next Generation of Cancer Professionals: the Fox Chase Cancer Center-University of Delaware Partnership for Undergraduate Research and Career Development | 000 | 2 | NIH | 1/31/2023 | $151,756 |
| | 2023 | 2023 | INSTITUTE FOR CANCER RESEARCH, THE | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R21AI168799 | Necroptosis in SARS-CoV-2 pathogenesis, evolution, and therapy | 000 | 2 | NIH | 1/17/2023 | $233,000 |
| | 2023 | 2023 | INSTITUTE FOR CANCER RESEARCH, THE | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R01CA238061 | Investigating genetic ancestry influences on oral cavity and laryngeal cancer survival disparities | 000 | 5 | NIH | 3/8/2023 | $578,893 |
| | 2023 | 2023 | INSTITUTE FOR CANCER RESEARCH, THE | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R01MD018146 | Examining the Relationship between Residential History at Midlife and Prostate Cancer Outcomes | 000 | 1 | NIH | 8/16/2023 | $542,620 |
| | 2023 | 2023 | INSTITUTE FOR CANCER RESEARCH, THE | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | U54CA272686 | Cancer Prevention-Interception Targeted Agent Discovery Program at Fox Chase Cancer Center | 001 | 2 | NIH | 8/17/2023 | $1,207,007 |
| | 2023 | 2023 | THE INSTITUTE FOR CANCER RESEARCH | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R01CA269660 | Pancreatic Cancer-Associated Fibroblasts: Function, Detection, and Regulation | 001 | 2 | NIH | 9/11/2023 | $254,999 |
| | 2023 | 2023 | INSTITUTE FOR CANCER RESEARCH, THE | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R01AI135025 | Mechanism, Function, and Exploitation of Influenza A Virus-Activated Cell Death | 001 | 7 | NIH | 9/11/2023 | $0 |
| | 2023 | 2023 | INSTITUTE FOR CANCER RESEARCH, THE | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | T32CA278766 | Training Grant in Precision Cancer Control | 000 | 1 | NIH | 9/14/2023 | $155,945 |
| | 2023 | 2023 | INSTITUTE FOR CANCER RESEARCH, THE | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R01CA269660 | Pancreatic Cancer-Associated Fibroblasts: Function, Detection, and Regulation | 000 | 2 | NIH | 5/31/2023 | $508,889 |
| | 2023 | 2023 | THE INSTITUTE FOR CANCER RESEARCH | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R01CA262466 | Assessing DNA Polymerase Theta as a Therapeutic Target in BRCA1 Mutant Cancer | 002 | 2 | NIH | 9/18/2023 | $200,000 |
| | 2023 | 2023 | INSTITUTE FOR CANCER RESEARCH, THE | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R01AI135025 | Mechanism, Function, and Exploitation of Influenza A Virus-Activated Cell Death | 000 | 7 | NIH | 8/9/2023 | $720,326 |
| | 2023 | 2023 | INSTITUTE FOR CANCER RESEARCH, THE | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R03CA280410 | Role of the Parkinson's susceptibility gene LRRK2 in NFAT-mediated malignant mesothelioma tumorigenesis | 000 | 1 | NIH | 4/25/2023 | $94,000 |
| | 2023 | 2023 | INSTITUTE FOR CANCER RESEARCH, THE | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R01CA281212 | Elucidating the critical role of Wee1 in GIST | 000 | 1 | NIH | 2/10/2023 | $430,050 |
| | 2023 | 2023 | INSTITUTE FOR CANCER RESEARCH, THE | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R01CA262466 | Assessing DNA Polymerase Theta as a Therapeutic Target in BRCA1 Mutant Cancer | 001 | 2 | NIH | 2/16/2023 | $421,449 |
| | 2023 | 2023 | INSTITUTE FOR CANCER RESEARCH, THE | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R21CA277402 | A Phase I Proof-of-Concept Study of CBL0137 Combined with Ipilimumab and Nivolumab Therapy in Locally Advanced or Metastatic Melanoma | 000 | 1 | NIH | 6/14/2023 | $263,670 |
| | 2023 | 2023 | INSTITUTE FOR CANCER RESEARCH, THE | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R21CA280446 | Interaction of cannabidiol (CBD) with targeted inhibitors of essential cancer signaling pathways | 000 | 1 | NIH | 3/22/2023 | $255,105 |
| | 2023 | 2023 | INSTITUTE FOR CANCER RESEARCH, THE | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R00ES031148 | Repair of Oxidative Damage in G-Quadruplex Promoter DNA | 000 | 4 | NIH | 2/24/2023 | $249,000 |
| | 2023 | 2023 | INSTITUTE FOR CANCER RESEARCH, THE | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R35GM122517 | Structural Bioinformatics of Proteins and Protein Complexes and Applications to Cancer Biology | 000 | 6 | NIH | 5/24/2023 | $744,480 |
| | 2023 | 2023 | INSTITUTE FOR CANCER RESEARCH, THE | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R01MD018511 | Neighborhood, social connectedness, and allostatic load in US Chinese immigrants | 000 | 1 | NIH | 5/16/2023 | $597,379 |
| | 2023 | 2023 | INSTITUTE FOR CANCER RESEARCH, THE | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R01CA269975 | Small-molecule exploitation of ZBP1-driven nuclear necroptosis for cancer immunotherapy | 000 | 1 | NIH | 12/16/2022 | $758,985 |
| | 2023 | 2023 | INSTITUTE FOR CANCER RESEARCH, THE | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | U01CA260369 | Optimization of urinary DNA deep sequencing tests to enhance clinical staging of bladder cancer patients | 000 | 3 | NIH | 8/3/2023 | $413,702 |
| | 2023 | 2023 | INSTITUTE FOR CANCER RESEARCH, THE | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R01AI171568 | Role of ZBP1 in pathogenesis of Salmonella biofilms | 000 | 1 | NIH | 5/11/2023 | $846,101 |
| | 2023 | 2023 | INSTITUTE FOR CANCER RESEARCH, THE | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | K99GM148819 | Elucidating the epigenetic regulation of extracellular matrix and virus-induced fibroblast activation | 000 | 1 | NIH | 1/17/2023 | $125,000 |
| | 2023 | 2023 | INSTITUTE FOR CANCER RESEARCH, THE | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R01CA259188 | Investigating the IL-1R Pathway in Anaplastic Large Cell Lymphoma for Targeted Therapy | 000 | 3 | NIH | 3/24/2023 | $395,588 |
| | 2023 | 2023 | INSTITUTE FOR CANCER RESEARCH, THE | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R35GM119560 | Molecular Mechanisms Underlying Adaptor-Mediated Integrin Signaling in a Species-Specific Manner | 002 | 7 | NIH | 8/16/2023 | $66,704 |
| | 2023 | 2023 | INSTITUTE FOR CANCER RESEARCH, THE | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R35GM119560 | Molecular Mechanisms Underlying Adaptor-Mediated Integrin Signaling in a Species-Specific Manner | 001 | 7 | NIH | 3/29/2023 | $48,152 |
| | 2023 | 2023 | INSTITUTE FOR CANCER RESEARCH, THE | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R01CA283396 | Divergent Functions of ERK Substrate Binding Domains in Pathogenesis of Myeloproliferative Neoplasms | 000 | 1 | NIH | 7/6/2023 | $707,046 |
| | 2023 | 2023 | INSTITUTE FOR CANCER RESEARCH, THE | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R01CA251674 | Analysis and Therapeutic Targeting of the Linear-Ubiquitination Pathway in Hodgkin Lymphoma | 000 | 3 | NIH | 5/25/2023 | $419,207 |
| | 2023 | 2023 | INSTITUTE FOR CANCER RESEARCH, THE | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R01GM135293 | Dissecting BRCA1-PALB2 Activity in DNA Repair and Development | 000 | 4 | NIH | 7/28/2023 | $386,563 |
| | 2023 | 2023 | INSTITUTE FOR CANCER RESEARCH, THE | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R35GM119560 | Molecular Mechanisms Underlying Adaptor-Mediated Integrin Signaling in a Species-Specific Manner | 000 | 7 | NIH | 1/4/2023 | $433,373 |
| | 2023 | 2023 | INSTITUTE FOR CANCER RESEARCH, THE | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | P01AI102853 | Molecular basis of ?? T lineage specification | 000 | 10 | NIH | 7/21/2023 | $1,980,932 |
| | 2023 | 2023 | INSTITUTE FOR CANCER RESEARCH, THE | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R01MD017675 | Reducing Urban Cervical Cancer Disparities Using a Tailored mHealth Intervention to Enhance Colposcopy Attendance | 000 | 1 | NIH | 6/4/2023 | $709,137 |
| | 2023 | 2023 | INSTITUTE FOR CANCER RESEARCH, THE | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R37AI110985 | Regulation of hematopoiesis by ribosomal protein paralogs | 000 | 9 | NIH | 1/26/2023 | $561,000 |
| | 2023 | 2023 | INSTITUTE FOR CANCER RESEARCH, THE | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R35GM150538 | Telomerase RNP Prisonbreaks from Phase-Separated Nuclear Body | 000 | 1 | NIH | 6/29/2023 | $470,000 |
| | 2023 | 2023 | INSTITUTE FOR CANCER RESEARCH, THE | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R03CA273479 | Pancreatic adenocarcinoma secretome as a dynamic biomarker for patient stromal reprogramming efficacy | 000 | 2 | NIH | 6/30/2023 | $94,000 |
| | 2023 | 2023 | INSTITUTE FOR CANCER RESEARCH, THE | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R01CA245871 | MTAP, 5'-deoxy-5'-methylthioadenosine, and the dysregulation of symmetric dimethylarginine in cancer | 000 | 4 | NIH | 5/12/2023 | $419,207 |
| | 2023 | 2023 | INSTITUTE FOR CANCER RESEARCH, THE | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | UG3HL170034 | Asian American Community Cohort and Equity Study (ACCESS) | 000 | 1 | NIH | 8/4/2023 | $306,624 |
| | 2023 | 2023 | INSTITUTE FOR CANCER RESEARCH, THE | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R01CA262551 | Folic Acid Supplementation and Colitis-associated Colon Carcinogenesis | 000 | 2 | NIH | 4/17/2023 | $484,469 |
| | 2023 | 2023 | INSTITUTE FOR CANCER RESEARCH, THE | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R01HL150190 | The role of microhomology-mediated end joining in Fanconi anemia pathogenesis | 000 | 4 | NIH | 1/26/2023 | $467,500 |
| | 2023 | 2023 | INSTITUTE FOR CANCER RESEARCH, THE | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R01CA248655 | Evidence-Based Approach to Empower Asian American Women in Cervical Cancer Screening | 001 | 4 | NIH | 2/28/2023 | $602,047 |
| | 2023 | 2023 | INSTITUTE FOR CANCER RESEARCH, THE | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | UG3HL170034 | Asian American Community Cohort and Equity Study (ACCESS) | 000 | 1 | NIH | 8/4/2023 | $80,001 |
| | 2023 | 2023 | INSTITUTE FOR CANCER RESEARCH, THE | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R01GM141513 | Designing selective kinase inhibitors via deep learning | 002 | 2 | NIH | 8/14/2023 | $181,277 |
| | 2023 | 2023 | INSTITUTE FOR CANCER RESEARCH, THE | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R01GM141513 | Designing selective kinase inhibitors via deep learning | 000 | 2 | NIH | 11/21/2022 | $494,601 |
|
